Delivery Order 75F40126D00015-75F40126F19001

The Department of Health and Human Services Food and Drug Administration awarded a $317,900 firm fixed price purchase order to Axion Biosystems, Inc. for the delivery of one Axion Biosystem Maestro Multi-Well Microelectrode Array system. The system will meet the technical requirements outlined in the FDA's February 2023 special notice, including integrated signal amplification, digitization and stimulation hardware, environmental controls, automated plate docking, stimulus design capabilities,...

<p>The Food and Drug Administration awarded a purchase order to Axion Biosystems, Inc. for $39,900 on May 10, 2022, for an impedance module upgrade and software for an Axion Biosystems Maestro Pro instrument. The order is set aside for total small business. Work is performed in Atlanta, Georgia, with an ultimate completion date of October 11, 2022. Pricing is firm fixed price.</p>

This federal contract award is for the procurement of microelectrode array (MEA) lab equipment, including the Maestro multi-well MEA system, from Axion Biosystems, Inc. The $163,750.00 firm fixed-price purchase order was issued by the Department of Health and Human Services' Food and Drug Administration. The contract has a completion date of December 1, 2022 and includes two 1-year post-warranty maintenance option periods. Axion Biosystems is a life science company that develops technologies for...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment. The $218,346.00 contract is for the Maestro Multiwell System and related service agreement. Axion Biosystems provides the FDA with its proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and consumables to support the agency's biomedical research and drug...

This federal contract award, with ID HHSF223201510728P, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of advanced live cell analysis technologies and laboratory equipment. The $135,232.00 firm fixed-price purchase order is for the AXION MAESTRO 768D MULTI ELECTRODE RSVP 1043 system, which is likely used in biomedical and drug development research. Axion Biosystems has received numerous prior federal contract awards,...

The Environmental Protection Agency's Office of Research and Development issued a purchase order to Axion Biosystems, Inc. for 48-well microelectrode array plates valued at $56,925.00, awarded April 18, 2025, under a total small business set-aside. Work is performed in Atlanta, Georgia, with an ultimate completion date of May 1, 2026. The requirement calls for brand-specific CytoView MEA supplies. The purchase order originated from EPA solicitation posted April 3, 2025, with quotes due April 11,...

This federal contract award, with ID HHSF223201510126A, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The $219,708.00 firm-fixed-price purchase order is for the acquisition of a high-throughput microelectrode assay system, plus 4 years of preventive maintenance services. The award does not have a set-aside designation. Axion Biosystems is a provider of live cell...

The National Institutes of Health National Institute on Drug Abuse awarded a $535,550 firm fixed price purchase order to Axion Biosystems, Inc. for the acquisition of a Maestro APEX automated incubator system and a Maestro MEA 768-channel multi-well system. The systems will support NIDA's therapeutic development programs, as solicited in the combined synopsis and solicitation seeking offers for the goods and services. Axion Biosystems will provide the Maestro systems, four days of installation...

This is a $12,500 firm fixed-price purchase order contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian federal agency, to Axion Biosystems, Inc., a foreign-owned manufacturer of specialized laboratory equipment and instruments. The contract is for the delivery of an optical stimulation system, which is likely to support NIAAA's biomedical research initiatives involving the real-time monitoring of neural and cardiac activity. Axion Biosystems has a strong...

<p>The National Center for Advancing Translational Sciences awarded a purchase order to Axion Biosystems, Inc. for a service and maintenance agreement covering an Axion Biosystems instrument, valued at $110,200.00, on September 14, 2024. Performance is located in Atlanta, Georgia. The order is priced on a firm fixed price basis with an ultimate completion date of September 13, 2025.</p>